Back to Search
RAYMOND COLEMAN, M.D.
M.D.
Internal Medicine Physician
NPI: 1487781639Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD019877E(PA)
Research & Publications (20)
Finding and characterizing tunnels in macromolecules with application to ion channels and pores.
PMID 18849407·Biophys J·2009
8-other
Travel depth, a new shape descriptor for macromolecules: application to ligand binding.
PMID 16934837·J Mol Biol·2006
8-other
Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
PMID 19648649·J Biol Chem·2009
7-preclinical
A direct and efficient total synthesis of the tubulin-binding agents ceratamine A and B; use of IBX for a remarkable heterocycle dehydrogenation.
PMID 19385610·Org Lett·2009
7-preclinical
New results from the use of bisphosphonates in cancer patients.
PMID 19561507·Curr Opin Support Palliat Care·2009
6-review
Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer.
PMID 19065127·Nat Clin Pract Endocrinol Metab·2009
8-other
Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
PMID 19447606·Eur J Cancer·2009
8-other
Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase.
PMID 19386600·J Biol Chem·2009
7-preclinical
A practical method of chronic ethanol administration in mice.
PMID 18369910·Methods Mol Biol·2008
7-preclinical
Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy.
PMID 18344903·Pediatr Res·2008
4-observational
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies.
PMID 18486346·Cancer Treat Rev·2008
6-review
44th Annual Meeting of the American Society of Clinical Oncology.
PMID 18649408·Gynecol Oncol·2008
8-other
Rationale for combination use of targeted agents in ovarian cancer: do we have one?
PMID 18623195·Cancer·2008
8-other
Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux.
PMID 17904345·J Nutr Biochem·2008
7-preclinical
Commentary: Controversies in NICE guidance on metastatic spinal cord compression.
PMID 19039018·BMJ·2008
8-other
Practical guidance for the management of aromatase inhibitor-associated bone loss.
PMID 18448451·Ann Oncol·2008
8-other
Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
PMID 18082328·Cancer Treat Rev·2008
6-review
The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: current clinical trials.
PMID 18584855·Gynecol Oncol·2008
8-other
Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.
PMID 18579314·Cancer Treat Rev·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 S 54TH ST, STE 227
PHILA, PA 19143 - Phone
- (215) 528-5288
Quick Facts
- NPI
- 1487781639
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile